(HealthDay)—Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17 years, the U.S. Food and Drug Administration announced yesterday.
May 1, 2019
0
1
A new study from The Westmead Institute for Medical Research has identified a genetic variant associated with liver fibrosis (scarring) in chronic hepatitis C patients. This finding is a step toward reducing the number of ...
Apr 3, 2019
0
1
Introducing hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 percent, according to a study in which the University of Barcelona (UB) took part. The study analysed the efficiency and ...
Mar 14, 2019
0
2
(HealthDay)—Meeting World Health Organization (WHO) targets for chronic hepatitis B by 2030 will be cost-effective, according to a report published in the July issue of Health Affairs.
Jul 27, 2018
0
0
(HealthDay)—For hepatitis B virus (HBV) carriers, hepatitis B virus core-related antigen (HBcrAg) levels are associated with progression to cirrhosis, according to a study published online Sept. 15 in the Journal of Gastroenterology ...
Sep 21, 2017
0
0
Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related ...
Apr 24, 2017
0
0
(HealthDay)—For patients with hepatitis C virus (HCV) infection and biopsy-proven cirrhosis, sustained viral response (SVR) is associated with a reduction in critical events, both liver and non-liver related, according ...
Jan 4, 2017
0
0
A US jury has ordered pharmaceutical giant Gilead Sciences to pay $2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.
Dec 16, 2016
0
0
Patients suffering from liver cirrhosis often die of life-threatening bacterial infections. In these patients the immune cells are unable to eliminate the bacterial infections. Scientist at the University of Bonn and TU Munich ...
Jul 19, 2016
0
1
A new study by researchers at Baylor College of Medicine found that treatment and cure of chronic hepatitis C reduce the risk of hepatocellular carcinoma (HCC), especially if given early, before cirrhosis develops, and while ...
Apr 25, 2016
0
13
